• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVAMED (ANTALYA) MULTIFILTRATEPRO SECUCAS CI-CA HD; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVAMED (ANTALYA) MULTIFILTRATEPRO SECUCAS CI-CA HD; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number 36-8116-0
Device Problem Fluid/Blood Leak (1250)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 12/03/2023
Event Type  malfunction  
Event Description
It was reported that a multifiltrate pro secucas ci-ca hd had a blood leak that occurred in the tubing system (pre-filter pressure dome) 72 hours into a patient¿s continuous renal replacement therapy (crrt) treatment.The patient experienced approximately 200 ml of blood loss.The sample was reported to be available for evaluation.Additional information requested but has not been obtained.
 
Manufacturer Narrative
Investigation: machine files were not provided for investigation.Original sample was available and analyzed accordingly.Review of device history record (dhr) revealed batch production record controls resulted with conformity.Non-conformity was not observed during manufacturing process.A 100% testing of each machine ensures that devices are delivered according to specifications.A blood contaminated mfc bloodline without blister package was received for investigation.Visual inspection: the sample was checked for component defect, conformity with the product specification.Leakage test: the sample was checked under air/liquid pressure for assembly failure and leakage.Review of instruction for use (ifu) and/or label noted that the described situation is adequately addressed in ifu and/or on the label.There is no indication that the reported failure relates to falsification.No information found that product is related to falsification or an unauthorized configuration.As result of examination, it was observed that there was rupture causing leakage on the membrane of the pressure dome.The complaint was admitted, however exact reason of the defect could not be determined.Raw material-based defect, improper connection of the pressure dome or handling process during treatment may be considered as possible reasons, but not limited to.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MULTIFILTRATEPRO SECUCAS CI-CA HD
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
NOVAMED (ANTALYA)
antalya freezone ctr branch
liman s b mah.4. sk.no:16
konyaalti-antalya 07070
TU  07070
Manufacturer (Section G)
NOVAMED (ANTALYA)
antalya freezone ctr branch
liman s b mah.4. sk.no:16
konyaalti-antalya 07070
TU   07070
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key18866753
MDR Text Key337229663
Report Number0001225714-2024-00024
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
EUA200149
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 03/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number36-8116-0
Device Lot NumberE9UC064
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Device AgeMO
Date Manufacturer Received12/04/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MULTIFILTRATE PRO MACHINE
-
-